Contemporary treatment of renovascular hypertension

 A.V. Khokhlov, M.V. Shymanko, A.O. Maksakov, M.V. Stan, K.S. Boiko, V.Yu. Kundin

References

1. Bax L, Woittiez AJ, Kouwenberg HJ, et al. Stent placement in patients with atherosclerotic renal artery stenosis and impaired renal function: a STAR randomized trial. Ann Intern Med. 2009;150 (12):840-848.
2. Bloch MJ, Trost DW, Pickering TG, et al. Prevention of recurrent pulmonary edema in patients with bilateral renovascular disease through renal artery stent placement. Am J Hypertens. 1999;12(Pt.1):1-7.
3. Blum U, Krumme B, Flügel P, et al. Treatment of ostial renal-artery stenoses with vascular endoprostheses after unsuccessful balloon angioplasty. N Engl J Med. 1997;336:459-465.
4. Burket MW, Cooper CJ, Kennedy DJ, et al. Renal artery angioplasty and stent placement: predictors of a favorable outcome. Am Heart J 2000;139:64-71.
5. Cooper CJ, Murphy TP, Cutlip DE, et al. Stenting and Medical Therapy for Atherosclerotic Renal-Artery Stenosis (CORAL trial). New Engl J Med 2014;370:13-22.
6. Cooper CJ, Murphy TP, Matsumoto A, et al. Stent revascularization for the prevention of cardiovascular and renal events among patients with renal artery stenosis and systolic hypertension: rationale and design of the CORAL trial. Amer Heart J. 2006;152:59-66.
7. Davies MG, Saad WE, Peden EK, et al. The long-term outcomes of percutaneous therapy for renal artery fibromuscular dysplasia. J Vasc Surg. 2008;48:865-871.
8. Drieghe B, Madaric J, Sarno G, et al. Assessment of renal artery stenosis: side-by-side comparison of angiography and duplex ultrasound with pressure gradient measurements. Eur Heart J. 2008;29:517-524.
9. Foy A, Ruggiero NJ. II, Filippone EJ. Revascularization in renal artery stenosis. Cardiol Rev. 2012;20:189-193.
10. Furkalo S, Khasyanova I. Angyoplasty and renal stenting in patients after kidney transplantation from a live-relative donor. Euro PC Rabtract-book. 2015.210 p.
11. Greco BA, Breyer JA. The natural history of renal artery stenosis: who should be evaluated for suspected ischemic nephropathy? Semin Nephrol. 1996;16:2-11.
12. Harden PN, MacLeod MJ, Rodger RS, et al. Effect of renal-artery stenting on progression of renovascular renal failure. Lancet. 1997;349:1133-1136.
13. Jaarsveldvan BC, Krijnen P, Pieterman H, et al. The effect of balloon angioplasty on hypertension in atherosclerotic renal-artery stenosis. Dutch Renal Artery Stenosis Intervention Cooperative Study Group. New Engl J Med. 2000;342:1007-1014.
14. Jaff MR, Bates M, Sullivan T, et al. Significant reduction in systolic blood pressure following renal artery stenting in patients with uncontrolled hypertension: results from the HERCULES trial. Catheter Cardiovasc Interv. 2012;80:343-350.
15. Kalra PA, Chrysochou C, Green D, et al. The benefit of renal artery stenting in patients with atheromatous renovascular disease and advanced chronic kidney disease. Catheter Cardiovasc Interv. 2010;75:1-10.
16. Kane GC, Xu N, Mistrik E, et al. Renal artery revascularization improves heart failure control in patients with atherosclerotic renal artery stenosis. Nephrol Dial Transplant. 2010;25:813-820.
17. Korsakas S, Mohaupt MG, Dinkel H.P, et al. Delay of dialysis in end-stage renal failure: prospective study on percutaneous renal artery interventions. Kidney Int. 2004;65:251-258.
18. Lewington S, Clarke R, Qizilbash N, et al. Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet. 2002;360:1903-1913.
19. Management of Patients With Peripheral Artery Disease (Compilation of 2005 and 2011 ACCF/AHA Guideline Recommendations). A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol. 2013;61:1555-1570.
20. Marini M, Fernandez-Rivera C, Cao I, et al. Treatment of transplant renal artery stenosis by percutaneous transluminal angioplasty and/or stenting: study in 63 patients in a single institution. Transplant Proc. 2011;43 (6):2205-2207.
21. Murphy TP, Soares G, Kim M. Increase in utilization of percutaneous renal artery interventions by Medicare beneficiaries, 1996-2000. Am J Roentgenol. 2004;183:561-568.
22. Pappas P, Zavos G, Kaza S, et al. Transplant. Proc. 2008;40 (5):1391-1396.
23. Plouin PF. Stable patients with atherosclerotic renal artery stenosis should be treated first with medical management. Am J Kidney Dis. 2003;42:851-857.
24. Plouin PF, Chatellier G, Darne B, Raynaud A. Blood pressure outcome of angioplasty in atherosclerotic renal artery stenosis: a randomized trial. Essai Multicentrique Medicaments vs Angioplastie (EMMA) Study Group. Hypertension. 1998;31:823-829.
25. Rajan DK, Stavropoulos WK, Shlansky-Goldberg RD. Management of Transplant Renal Artery Stenosis. Semin Intervent Radiol. 2004;21 (4):259-269.
26. Rastan A, Krankenberg H, Muller-Hulsbeck S, et al. Improved renal function and blood pressure control following renal artery angioplasty: the renal artery angioplasty in patients with renal insufficiency and hypertension using a dedicated renal stent device study (PRECISION). Euro Intervention. 2008;4:208-213.
27. Rocha-Singh K, Jaff MR, Lynne Kelley E. Rena lartery stenting with noninvasive duplex ultrasound follow-up: 3-year results from the RENAISSANCE renal stent trial. Catheter Cardiovasc Interv. 2008;72:853-862.
28. Rocha-Singh K, Jaff M.R, Rosenfield K. Evaluation of the safety and effective ness of renal artery stenting after unsuccessful balloon angioplasty: the ASPIRE-2study. J Amer Coll Cardiol. 2005;46:776-783.
29. Safian RD, Textor SC. Renal-artery stenosis. N Engl J Med. 2001;344:431-442.
30. Schreiber M.J, Pohl MA, Novick AC. Then atural history of atherosclerotic and fibrous renal artery disease. Urol. Clin. North Amer. 1984;11:383-392.
31. Slovut DP, Olin JW. Fibromuscular dysplasia. N Engl J Med. 2004;350:1862-1871.
32. Thatipelli M, Misra S, Johnson CM, et al. Renal artery stent placement for restoration of renal function in hemodialysis recipients with renal artery stenosis. J VascInterv Radiol. 2008;19 (11):1563-1568.
33. Trinquart L, Mounier-Vehier C, Sapoval M, et al. Efficacy of revascularization for renal artery stenosis caused by fibromuscular dysplasia: a systematic review and meta-analysis. Hypertension. 2010;56:525-532.
34. Van de Ven PJ, Kaatee R, Beutler JJ, et al. Arterial stenting and balloon angioplasty in ostial atherosclerotic renovascular disease: a randomised trial. Lancet. 1999;353:282-286.
35. Van Jaarsveld BC, Krijnen P, Pieterman H, et al. The effect of balloon angioplasty on hypertension in atherosclerotic renal-artery stenosis. N. Engl J Med.-2000;342:1007-1014.
36. Watson PS, Hadjipetrou P, Cox SV, et al. Effect of renal artery stenting on renal function and size in patients with atherosclerotic renovascular disease. Circulation. 2000;102:1671-1677.
37. Webster J, Marshall F, Abdalla M, et al. Randomised comparison of percutaneous angioplasty vs continued medical therapy for hypertensive patients with atheromatous renal artery stenosis. Scottish and Newcastle Renal Artery Stenosis Collaborative Group. J Hum Hypertens. 1998;12:329-335.
38. Wheatley K, Ives N, Gray R, Kalra PA, et al. Revascularization vs. Medical therapy for renal-artery stenosis. N Engl J Med. 2009;361:1953-1962.
39. Wheatley K, Ives N, Kalra PA, et al. ASTRAL Revascularization versus Medical Therapy for Renal-Artery Stenosis. New Engl J Med. 2009;361:1953-1962.
40. White CJ, Jaff MR, Haskal ZJ, et al. Indications for renal arteriography at the time of coronary arteriography: a science advisory from the American Heart Association Committeeon Diagnostic and Interventional Cardiac Catheterization, Councilon Clinical Cardiology, and the Councilson Cardiovascular Radiology and Intervention and on Kidney in Cardiovascular Disease. Circulation. 2006;114:1892-1895.
41. Yu H, Zhang D, Haller S, et al. Determinants of renal function in patients with renal artery stenosis. Vasc Med. 2011;16:331-338.
42. Zeller T, Frank U, Muller C, et al. Predictors of improved renal function after percutaneous stentsupported angioplasty of severe herosclerotic ostial renal artery stenosis. Circulation. 2003;108:2244-2249.
43. Zeller T, Frank U, Muller C, et al. Stent-supported angioplasty of severe atherosclerotic renal artery stenosis preserves renal function and improves blood pressure control: long-term results from a prospective registry of 456 lesions. J Endovasc Ther. 2004;11:95-106.
44. Zierler RE, Bergelin RO, Davidson RC, et al. A prospective study of disease progression in patients with atherosclerotic renal artery stenosis. Am J Hypertens. 1996;9:1055-1061.
45. 2013 ESH/ESC Guidelines for the management of arterial hypertension. The European Society of Hypertension (ESH) and European Society of Cardiology (ESC), 2013.
46. 2011 ESC Guidelines on the diagnosis and treatment of peripheral artery diseases. The European Society of Cardiology, 2011.

Clinical features and choice of the revascularization method in patients with stable coronary heart disease and preserved left ventricular ejection fraction

Yu.A. Borkhalenko, О.J. Zharinov, K.O. Mikhaliev, О.А. Yepanchintseva, А.V. Khokhlov, B.М. Тоdurov

References

1. Medicinal treatment of stable angina pectoris. Methodical recommendations of the Working Group on Atherosclerosis and Chronic Chondritis of the Association of Cardiologists of Ukraine. 2010. (in Ukr.).
2. Cardiovascular disease. Classification, standards of diagnosis and treatment: Methodical recommendations of the Association of Cardiologists of Ukraine. Ed. by VM Kovalenko, MI Lutay, Yu.M. Sirenko. 2010. (in Ukr.).
3. ACC/AATS/AHA/ASE/ASNC/SCAI/SCCT/STS 2017 Appropriate Use Criteria for Coronary Revascularization in Patients With Stable Ischemic Heart Disease. JACC. 2017 Mar. https://doi.org/10.1016/j.jacc.2017.02.001
4. Bravata DM, McDonald KM, Gienger AL, et al. Comparative Effectiveness of Percutaneous Coronary Interventions and Coronary Artery Bypass Grafting for Coronary Artery Disease. Journal of General Internal Medicine. Ann Intern Med 2007;147(10):703-716.
5. Dorr DA, Jones SS, Burns L, et al. Use of health-related, quality-of-life metrics to predict mortality and hospitalizations in community-dwelling seniors. J Am Geriatr Soc. 2006;54(4):667-673.
6. Durmaz T, Ozdemiir O, Ozdemiir BA, et al. Factors affecting quality of life in patients with coronary heart disease. Turkish J Med Sci. 2009;39(3):343-351.
7. Hak T, Willems D, van der Wal G, et al. A qualitative validation of the Minnesota Living with Heart Failure Questionnaire. Qual Life Res. 2004;13:417-426.
8. Hoekstra T, Lesman-Leegte I, van Veldhuisen Dirk J, et al. Quality of life is impaired similarly in heart failure patients with preserved and reduced ejection fraction. Eur J Heart Fail. 2013;15(1):94.
9. Kim C, Bernstein SJ. Quality of life assessment for chronic stable angina. Expert Rev Pharmacoecon Outcomes Res. 2003;3(5):637-650.
10. Lie I, Arnesen H, Sandvik L, Hamilton G, Bunch EH. Health-related quality of life after coronary artery bypass grafting. The impact of a randomised controlled home-based intervention program. Qual Life Res. 2009;18(2):201-207.
11. Loponen P, Luther M, Korpilahti K, Wistbacka JO, et al. HRQOL after coronary artery bypass grafting and percutaneous coronary intervention for stable angina. Scand. Cardiovasc. J. 2009;43(2):94-99.
12. Lukkarinen H, Hentinen M. Assessment of quality of life with the Nottingham Health Profile among patients with coronary heart disease. J. Adv. Nurs. 1997;26(1):73-84.
13. Luttik ML, Jaarsma T, Veeger N, van Veldhuisen DJ. Marital status, quality of life, and clinical outcome in patients with heart failure. Heart Lung. 2006;35(1):3-8.
14. Montalescot G, Sechtem U, Achenbach S. еt al. Guidelines on the management of stable coronary artery disease: The Task Force оn the management of stable coronary artery disease of the European Society of Cardiology. ESC, 2013. Eur Heart J. 2013;34:2949-3004.
15. Naik H, White AJ, Chakravarty T, et al. A meta-analysis of 3,773 patients treated with percutaneous coronary intervention or surgery for unprotected left main coronary artery stenosis. JACC Cardiovasc Interv. 2009;2(8):739-747.
16. Norris CM, Saunders LD, Ghali WA, et al. Health-related quality of life outcomes of patients with coronary artery disease treated with cardiac surgery, percutaneous coronary intervention or medical management. Can J Cardiol. 2004;20(12):1259-1266.
17. Rumsfeld JS, Magid DJ, Plomondon ME, et al. Health-related quality of life after percutaneous coronary intervention versus coronary bypass surgery in high-risk patients with medically refractory ischemia. J Am Coll Cardiol. 2003;41(10):1732-1738.
18. Spertus JA, Winder JA, Dewhurst TA, et al. Development and evaluation of the Seattle Angina Questionnaire: a new functional status measure for coronary artery disease. J Am Coll Cardiol. 1995;25(2):333-341.
19. Spertus JA, Winder JA., Dewhurst Timothy A, et al. Monitoring the quality of life in patients with coronary artery disease. Amer. J. Heart. 1994;74:1240-1244.
20. Unsar S, Sut N, Durna Z. Health-related quality of life in patients with coronary artery disease. J Cardiovasc Nurs. 2007;22(6):501-507.
21. Ware JE, Sherbourne CD. The MOS 36-item Short-Form Health Survey (SF-36): Conceptual framework and item selection. Medical Care. 1992;30:473-483.
22. Windecker S, Kolh P, Alfonso F, et al. 2014 ESC/EACTS Guidelines on myocardial revascularization. The Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS). Eur Heart J. 2014;35:2541-2619.

Reoperation after radical correction tetralogy of Fallot: results and prospects

M.F. Zinkovskyi , A.G. Goryachev, S.O. Dykukha, L.R. Naumova, O.A. Pishchurin, M.Yu. Atamanyuk, V.M. Hondoga, S.O. Yakubyuk, R.M. Vitovsky

References

1. Danilov TYu Repeated operations in the long term after radical correction of tetralogy of Fallot. Мoskva. 2011. 328 p. (in Rus.).
2. Zinkovsky MF Congenital heart disease: a guide. Ed. by AF Vozianov. Кyiv: Knyga plus. 2009. 1170 p. (in Rus.).
3. Podzolkov VP, Kokshenev IV. The tetrad of Fallot. Мoskva. 2008. 494 p. (in Rus.).
4. Podzolkov VP, Kokshenev IV, Pursanov MG, et al. The results of repeated operations in the long term after radical correction of the tetralogy of Fallot and reconstruction of the outflow pathway of the right ventricle. Journal of Thoracic and Cardiovascular Surgery. 2007;4:11-17. (in Rus.).
5. Caspi J, Zalstein E, Zucker N, et al. Surgical management of tetralogy of Fallot in the first year of life. Ann. Thorac. Surg. 1999;68:1344-1348.
6. Faidutti В., Christenson J.T., Beghetti M, et al. How to diminish reoperation rates after initial repair of tetralogy of Fallot? Ann Thorac Surg. 2002;73 (1):96-101.
7. Hazekamp MG, Kurvers MM, Schoof PH, et al. Pulmonary valve insertion late after repair of tetralogy of Fallot. Eur J Cardiothorac Surg. 2001;19:667-670.
8. Knowles R, Veldtman G, Hickey E, et al. Functional health status of adults with tetralogy of Fallot: matched comparison with healthy siblings. Ann Thorac Surg. 2012;94:124-132.
9. Kobayashi J, Kawashima Y, Matsuda H, et al. Prevalence and risk factors of tricuspid regurgitation after correction of tetralogy of Fallot. J Thorac Cardiovasc Surg. 1991;102:611-616.
10. Monro JL, Alexiou C, Salmon AP, Keeton BR. Reoperations and survival after primary repair of congenital heart defects in children. J Thorac Cardiovasc Surg. 2003;126 (2):511-520.
11. Presbitero Р, Demarie D, Aruta E, et al. Results of total correction of tetralogy of Fallot performed in adults. Ann Thorac Surg. 1988;46:297-301.
12. Ruijter FH., Weenink I, Hitchcock FJ, et al. Right ventricular disfunction and pulmonary valve replacement after correction of tetralogy of Fallot. Ann Thorac Surg. 2002;73:1794-1800.

The possibilities of lung perfusion scintigraphy in the diagnosis of pulmonary embolism and chronic thromboembolic pulmonary hypertension

V.Yu. Kundin, M.V. Satyr, I.V. Noverko, A.V. Khokhlov

References

1. Myagkov AP, Rudik NV, Myagkov SA. Diagnosis of acute and chronic PE with CT-angiography. Radiologichnyi visnyk. 2015;1-2:21-26.(in Rus.).
2. Koval GYu, Mechev DS, Sivachenko TP. et al. Radiation diagnostics. Ed. GYu Koval. Kyiv: Medicine of Ukraine, 2009. 682 р.(in Ukr.).
3. Saveliev VS, Yablokov VG, Kiriyenko AI. Thromboembolism of the pulmonary artery. Diseases of the heart and blood vessels. Ed. E.I. Chazov. Мoskva: Medicine, 1992:390-402.(in Rus.).
4. Todurov BM, Khokhlov AV, Maksakov АА, Sohrab K, Shimanko MV. Experience of combined treatment of pulmonary thromboembolism and fibromyoma of uterus. Cardiac Surgery and Interventional Cardiology. 2012;1:45-49.(in Rus.).
5. Shaposhnikov SA, Chernov VN, Zabolotsky IB. Postoperative thrombotic complications. Statistical analysis over 50 years. Anesthesiology and Reanimatology. 2004;3:21-24.(in Rus.).
6. Anderson DR, Kahn SR, Rodger MA. et al. Computed tomographic pulmonary angiography vs ventilation-perfusion lung scanning in patients with suspected pulmonary embolism: a randomized controlled trial. JAMA. 2007;298(23):2743-2753.
7. D’Armini AM. Diagnostic advances and opportunities in chronic thromboembolic pulmonary hypertension. Eur Respir Rev. 2015;24(136):253-262.
8. Garcheva M. Impact of single photon emission tomography combined with computed tomography(SPECT/CT) in pulmonary examinations - short review with two case reports. Nucl Med Rev Cent East. Eur. 2014;17(2):101-107.
9. Gutte H, Mortensen J, Jensen C.V. et al. Detection of pulmonary embolism with combined ventilation-perfusion SPECT and low-dose CT: head-to-head comparison with multidetector CT angiography. J Nucl Med. 2009;50(12):1987-1992.
10. Konstantinides SV, Torbicki A, Agnelli G. et al. 2014 ESC Guidelines on the diagnosis and management of acute pulmonary embolism. Eur Heart J. 2015;36(39):2642.
11. Olsson KM, Meyer B, Hinrichs J. et al. Chronic thromboembolic pulmonary hypertension. Dtsch. Arztebl. Int. 2014;111(50):856-862.
12. Reinartz P, Wildberger JE, Schaefer W. et al. Tomographic imaging in the diagnosis of pulmonary embolism: a comparison between V/Q lung scintigraphy in SPECT technique and multislice spiral CT. J Nucl Med. 2004;45(9):1501-1508.
13. Taplin GV, Johnson DE, Dore EK. et al. Lung photoscans with macroaggregates of human serum radioalbumin. Experimental basis and initial clinical trials. Health phys. 1964;10:1219-1227.
14. Taplin GV, McDonald NS. Radiochemistry of macroaggregated albumin and newer lung scanning agents. Semin Nucl Med. 1971;1(2):132-152.

Experience with left ventricular assist device usage in the treatment of end-stage heart failure

B.M. Todurov, G.I. Kovtun, I.M. Kuzmich, M.V. Goncharenko, A.M. Druzhyna, A.O. Shpachuk, O.M. Postupalsky, S.O. Sheludko, S.M. Sudakevych, O.V. Stanyshevskyi, A.Yu. Melnyk

References

1. Boyle AJ, Russell SD, Teuteberg JJ, et al. Low thromboembolism and pump thrombosis with the Heart Mate II left ventricular assist device: analysis of outpatient anti-coagulation. J. Heart Lung. Transplant. 2009;28(9):881-887.
2. Chernyavskiy AM, Marchenko AV, Lomivorotov VV, et al. Left ventricular assist device implantation combined with surgical ventricular reconstruction. Tex. Heart Inst. J. 2012;39(5):627-629.
3. Dembitsky WP, Tector AJ, Park S, et al. Left ventricular assist device performance with long term circulatory support: lessons from the REMATCH trial. Ann. Thorac. Surg. 2004;78(6):2123-2130.
4. Farrar DJ, Hill JD, Pennington DG, et al. Preoperative and postoperative comparison of patients with univentricular and biventricular support with the thoratec ventricular assist device as a bridge to cardiac transplantation. J. Thorac. Cardiovasc. Surg. 1997;113:202-209.
5. Garbade J, et al. Current Trends in Implantable Left Ventricular Assist Devices. Cardiol. Res. Pract. 2011. 9 р.
6. Gorodeski EZ, et al. Prognosis on chronic dobutamine or milrinone infusions for stage D heart failure. Circ. Heart Fail. 2009;2:320-324.
7. Holman WL, Rayburn BK, McGiffin DC, et al. Infection in ventricular assist devices: prevention and treatment. Ann. Thorac. Surg. 2003;75(6):S48-S57.
8. McBride LR, Naunheim KS, Fiore AC, et al. Clinical experience with 111 thoratec ventricular assist devices. Ann. Thorac. Surg. 1999;67:1233-1238.
9. Miller LW, Pagani FD, Russell SD, et al. HeartMate II ClinicalInvestigators. Use of a continuous-flow device in patients awaiting heart transplantation. New Engl. J. Med. 2007;357(9):885-896.
10. Rose EA, Gelijns AC, Moskowitz AJ, et al. Randomized Evaluation of mechanical Assistance for the Treatment of Congestive Heart Failure(REMATCH) Study Group. Long-term use of a left ventricular assist device for end-stage heart failure. New Engl. J. Med. 2001;345(20):1435-1443.
11. Schmid C, Tjan TD, Etz C, et al. First clinical experience with the Incor left ventricular assist device. J. Heart Lung Transplant. 2005;4(9):1188-1194.
12. Stehlik J, Edwards LB, Kucheryavaya AY, et al. The registry of the international society for heart and lungtransplantation: twenty-seventh official adult heart transplant report 2010. J. Heart Lung Transplant. 2010;29:1089-1103.

НACC/AATS/AHA/ASE/ASNC/SCAI/SCCT/ STS 2017 Appropriate Use Criteria for coronary revascularization in patients with stable ischemic heart disease

Coronary Revascularization Writing Group: M. Patel (Chair), J. Calhoon, G. Dehmer, J. Grantham, T. Maddox, D. Maron, P. Smith

References

1. Adult Treatment Panel III. Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) Final Report. Circulation. 2002;106:3143-3421.
2. Aqel R, Zoghbi GJ, Hage F, et al. Hemodynamic evaluation of coronary artery bypass graft lesions using fractional flow reserve. Catheter Cardiovasc Interv. 2008;72:479-485.
3. Arnold SV, Grodzinsky A, Gosch KL, et al. Predictors of physician under-recognition of angina in outpatients with stable coronary artery disease. Circ Cardiovasc Qual Outcomes. 2016;9:554-559.
4. Barbash IM, Dvir D, Torguson R, et al. Prognostic implications of percutaneous coronary interventions performed according to the appropriate use criteria for coronary revascularization. Cardiovasc Revasc Med. 2013;14:316-320.
5. Barner HB, Barnett MG. Fifteen- to twenty-oneyear angiographic assessment of internal thoracic artery as a bypass conduit. Ann Thorac Surg. 1994;57:1526-1528.
6. Bradley SM, Spertus JA, Kennedy KF, et al. Patient selection for diagnostic coronary angiography and hospital-level percutaneous coronary intervention appropriateness: insights from the National Cardiovascular Data Registry. JAMA Intern Med. 2014;174:1630-1639.
7. Buchanan A. Medical paternalism. Philos Public Aff. 1978;7:370-390.
8. Chan PS, Rao SV, Bhatt DL, et al. Patient and hospital characteristics associated with inappropriate percutaneous coronary interventions. J Am Coll Cardiol. 2013;62:2274-2281.
9. Chewning B, Bylund CL, Shah B, et al. Patient preferences for shared decisions: a systematic review. Patient Educ Couns. 2012;86:9-18.
10. Chobanian AV, Bakris GL, Black HR, et al. Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension. 2003;42:1206-1252.
11. Coley C, Barry M, Mulley A. Screening for prostate cancer. Ann Intern Med. 1977;126:480-484.
12. De Bruyne B, Fearon WF, Pijls NH, et al. Fractional flow reserve-guided PCI for stable coronary artery disease. N Engl J Med. 2014;371:1208-1217.
13. De la Torre Hernandez JM, Hernandez HF, Alfonso F, et al. Prospective application of pre-defined intravascular ultrasound criteria for assessment of intermediate left main coronary artery lesions results from the multicenter LITRO study. J Am Coll Cardiol 2011;58:351-358.
14. Desai NR, Bradley SM, Parzynski CS, et al. Appropriate use criteria for coronary revascularization and trends in utilization, patient selection, and appropriateness of percutaneous coronary intervention. JAMA. 2015;314:2045-2053.
15. Fihn SD, Blankenship JC, Alexander KP, et al. 2014 ACC/AHA/AATS/PCNA/SCAI/STS focused update of the guideline for the diagnosis and management of patients with stable ischemic heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines, and the American Association for Thoracic Surgery, Preventive Cardiovascular Nurses Association, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. J Am Coll Cardiol. 2014;64:1929-1949.
16. Fihn SD, Gardin JM, Abrams J, et al. 2012 ACCF/ AHA/ACP/AATS/PCNA/SCAI/STS guideline for the diagnosis and management of patients with stable ischemic heart disease: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines, and the American College of Physicians, American Association for Thoracic Surgery, Preventive Cardiovascular Nurses Association, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. J Am Coll Cardiol. 2012;60:e44-164.
17. Hannan EL, Zhong Y, Walford G, et al. Coronary artery bypass graft surgery versus drug-eluting stents for patients with isolated proximal left anterior descending disease. J Am Coll Cardiol. 2014;64:2717-2726.
18. Harold JG, Bass TA, Bashore TM, et al. ACCF/AHA/ SCAI 2013 update of the clinical competence statement on coronary artery interventional procedures: a report of the American College of Cardiology Foundation/ American Heart Association/American College of Physicians Task Force on Clinical Competence and Training (Writing Committee to Revise the 2007 Clinical Competence Statement on Cardiac Interventional Procedures). J Am Coll Cardiol. 2013;62:357-396.
19. Hemingway H, Crook AM, Feder G, et al. Underuse of coronary revascularization procedures in patients considered appropriate candidates for revascularization. N Engl J Med. 2001;344:645-654.
20. Hendel RC, Patel MR, Allen JM, et al. Appropriate use of cardiovascular technology: 2013 ACCF appropriate use criteria methodology update: a report of the American College of Cardiology Foundation Appropriate Use Criteria Task Force. J Am Coll Cardiol. 2013;61:1305-1317.
21. Hillis LD, Smith P, Anderson J, et al. 2011 ACCF/ AHA guidelines for coronary artery bypass graft surgery: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol. 2011;58:e123- 210.
22. Hlatky MA, Boothroyd DB, Baker LC, Go AS. Impact of drug-eluting stents on the comparative effectiveness of coronary artery bypass surgery and percutaneous coronary intervention. Am Heart J. 2015;169:149-154.
23. Jacobs AK, Kushner FG, Ettinger SM, et al. ACCF/ AHA clinical practice guideline methodology summit report: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol. 2013;61:213-265.
24. Kern MJ, Samady H. Current concepts of integrated coronary physiology in the catheterization laboratory. J Am Coll Cardiol. 2010;55:173-185.
25. Ko DT, Guo H, Wijeysundera HC, et al. Assessing the association of appropriateness of coronary revascularization and clinical outcomes for patients with stable coronary artery disease. J Am Coll Cardiol. 2012;60:1876-1884.
26. Laouri M, Kravitz RL, French WJ, et al. Underuse of coronary revascularization procedures: application of a clinical method. J Am Coll Cardiol. 1997;29:891-897.
27. Levine GN, Bates ER, Blankenship JC, et al. 2011 ACCF/AHA/SCAI guideline for percutaneous coronary intervention: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventions. J Am Coll Cardiol. 2011;58:e44-122.
28. Levine GN, O’Gara PT, Bates ER, et al. 2015 ACC/ AHA/SCAI focused update on primary percutaneous coronary intervention for patients with ST-elevation myocardial infarction: an update of the 2011 ACCF/ AHA/SCAI Guideline for Percutaneous Coronary Intervention and the 2013 ACCF/AHA Guideline for the Management of ST-Elevation Myocardial Infarction: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Society for Cardiovascular Angiography and Interventions. J Am Coll Cardiol. 2016;67:1235-1250.
29. Lin GA, Fagerlin A. Shared decision making: state of the science. Circ Cardiovasc Qual Outcomes. 2014;7:328-334.
30. Marso SP, Teirstein PS, Kereiakes DJ, et al. Percutaneous coronary intervention use in the United States: defining measures of appropriateness. J Am Coll Cardiol Intv. 2012;5:229-235.
31. Mulley AG Jr, Eagle KA. What is inappropriate care? JAMA. 1988;260:540-541.
32. Nam CW, Mangiacapra F, Entjes R, et al. Functional SYNTAX score for risk assessment in multivessel coronary artery disease. J Am Coll Cardiol. 2011;58:1211-1218.
33. Patel MR, Dehmer GJ, Hirshfeld JW. et al, ACCF/SCAI/STS/AATS/AHA/ASNC/HFSA/ SCCT 2012 appropriate use criteria for coronary revascularization focused update: a report of the American College of Cardiology Foundation Appropriate Use Criteria Task Force, Society for Cardiovascular Angiography and Interventions, Society of Thoracic Surgeons, American Association for Thoracic Surgery, American Heart Association, American Society of Nuclear Cardiology, and the Society of Cardiovascular Computed Tomography. J. Am. Coll. Cardiol. 2012;59:857-881.
34. Sabik JF. III, Lytle BW, Blackstone EH, et al. Comparison of saphenous vein and internal thoracic artery graft patency by coronary system. Ann Thorac Surg. 2005;79:544-551.
35. Serruys PW, Morice MC, Kappetein AP, et al. Percutaneous coronary intervention versus coronaryartery bypass grafting for severe coronary artery disease. N Engl J Med. 2009;360:961-972.
36. Shafiq A, Arnold SV, Gosch K, et al. Patient and physician discordance in reporting symptoms of angina among stable coronary artery disease patients: insights from the Angina Prevalence and Provider Evaluation of Angina Relief (APPEAR) study. Am Heart J. 2016;175:94-100.
37. Smith SCJr, Benjamin EJ, Bonow RO, et al. AHA/ ACCF secondary prevention and risk reduction therapy for patients with coronary and other atherosclerotic vascular disease: 2011 update: a guideline from the American Heart Association and American College of Cardiology Foundation. J Am Coll Cardiol. 2011;58:2432-2446.
38. Stacey D, Bennett CL, Barry MJ, et al. Decision aids for people facing health treatment or screening decisions. Cochrane Database Syst. Rev. 2011:CD001431.
39. Ting HH, Brito JP, Montori VM. Shared decision making: science and action. Circ Cardiovasc Qual Outcomes. 2014;7:323-327.
40. Toth G, De BB, Casselman F, et al. Fractional flow reserve-guided versus angiography-guided coronary artery bypass graft surgery. Circulation. 2013;128:1405-1411.
41. Von Eschenbach A, Ho R, Murphy G, et al. American Cancer Society guideline for the early detection of prostate cancer: update 1997. CA Cancer J Clin. 1997:261-264.
42. Whitney SN, McGuire AL, McCullough LB. A typology of shared decision making, informed consent, and simple consent. Ann Intern Med. 2004;140:54-59.
43. Windecker S, Stortecky S, Stefanini G.G, et al. Revascularisation versus medical treatment in patients with stable coronary artery disease: network metaanalysis. BMJ. 2014;348:g3859.